Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T98264 | Target Info | |||
Target Name | Protein-tyrosine phosphatase SHP-1 (PTPN6) | ||||
Synonyms | Tyrosine-protein phosphatase non-receptor type 6; SH-PTP1; Protein-tyrosine phosphatase 1C; PTP1C; PTP-1C; Hematopoietic cell protein-tyrosine phosphatase; HCP | ||||
Target Type | Patented-recorded Target | ||||
Gene Name | PTPN6 | ||||
Biochemical Class | Phosphoric monoester hydrolase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Cytokine receptors | [+] 2 Cytokine receptors | + | |||
Interacting Target Name | Interleukin 4 receptor alpha (IL4R) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Interleukin-4 receptor subunit alpha; IL-4R-alpha; IL-4RA; IL4RA; IL-4R subunit alpha; IL-4 receptor subunit alpha; CD124 antigen; CD124; 582J2.1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Reconstituted Complex | [2] | |||
Interacting Target Name | Interleukin 3 receptor (CSF2RB) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IL5RB; IL-5R; IL3RB; GM-CSF/IL-3/IL-5 receptor common beta subunit; Cytokine receptor common subunit beta; CDw131; CD131 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [3] | |||
2 | Reconstituted Complex | [3] | |||
Kinases | [+] 6 Kinases | + | |||
Interacting Target Name | Tyrosine-protein kinase Kit (KIT) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; Proto-oncogene tyrosine-protein kinase Kit; Proto-oncogene c-Kit; Piebald trait protein; PBT; p145 c-kit; Mast/stem cell growth factor receptor Kit; C-kit; CD117 antigen; CD117 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [4] | |||
2 | Affinity Capture-Western | [5] | |||
3 | Reconstituted Complex | [5] | |||
Interacting Target Name | Vascular endothelial growth factor receptor 2 (KDR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | VEGFR-2; VEGFR2; VEGF-2 receptor; Protein-tyrosine kinase receptor flk-1; Kinase insert domain receptor; FLK-1; FLK1; Fetal liver kinase 1; CD309 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [6] | |||
2 | Co-localization | [6] | |||
3 | Yeast two hybrid | [7] | |||
Interacting Target Name | Focal adhesion kinase 2 (PTK2B) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Related adhesion focal tyrosine kinase; RAFTK; PYK2; Protein-tyrosine kinase 2-beta; Proline-rich tyrosine kinase 2; FAK2; FADK 2; Cell adhesion kinase beta; Calcium-regulated non-receptor proline-rich tyrosine kinase; Calcium-dependent tyrosine kinase; CAK-beta; CAKB; CADTK | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [8] | |||
2 | Affinity Capture-Western | [9] | |||
3 | Biochemical Activity | [9] | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Yeast two hybrid | [7] | |||
Interacting Target Name | Tyrosine-protein kinase SYK (SYK) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Spleen tyrosine kinase; p72-Syk | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [8] | |||
2 | Biochemical Activity | [11] | |||
Interacting Protein Name | Breakpoint cluster region protein (BCR) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ALL; BCR1; CML; D22S11; D22S662; PHL | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [12] | |||
2 | Affinity Capture-Western | [13] | |||
Other proteins | [+] 5 Other proteins | + | |||
Interacting Protein Name | Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CD305; LAIR.1 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [14] | |||
2 | Affinity Capture-Western | [15] | |||
3 | Reconstituted Complex | [15] | |||
4 | Yeast two hybrid | [14] | |||
5 | Yeast two hybrid | [16] | |||
Interacting Target Name | Platelet endothelial cell adhesion molecule (PECAM1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PECAM-1; PECA1; GPIIA'; EndoCAM; ECAM; CD31 antigen; CD31 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [17] | |||
2 | Far Western | [18] | |||
3 | Reconstituted Complex | [18] | |||
Interacting Protein Name | Lymphocyte cytosolic protein 2 (LCP2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SLP.76; SLP76 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [19] | |||
2 | Reconstituted Complex | [20] | |||
3 | Reconstituted Complex | [19] | |||
Interacting Target Name | B-cell receptor CD22 (CD22) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | T-cell surface antigen Leu-14; Siglec-2; SIGLEC2; Sialic acid-binding Ig-like lectin 2; Leu-14; B-lymphocyte cell adhesion molecule; BL-CAM | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Biochemical Activity | [22] | |||
Interacting Protein Name | Tyrosine-protein phosphatase non-receptor type substrate 1 (SIRPA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BIT; CD172A; MFR; MYD.1; P84; PTPNS1; SHPS1; SIRP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Co-crystal Structure | [23] | |||
2 | Yeast two hybrid | [16] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | The TORC1-activated Proteins, p70S6K and GRB10, Regulate IL-4 Signaling and M2 Macrophage Polarization by Modulating Phosphorylation of Insulin Rec... J Biol Chem. 2016 Nov 25;291(48):24922-24930. | ||||
REF 2 | Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation. J Immunol. 2001 Dec 1;167(11):6382-7. | ||||
REF 3 | SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates. J Biol Chem. 1997 May 30;272(22):14470-6. | ||||
REF 4 | SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Mol Cell Biol. 1998 Apr;18(4):2089-99. | ||||
REF 5 | Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand. Mol Cell Biol. 1993 Jun;13(6):3350-8. | ||||
REF 6 | TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation. FASEB J. 2017 May;31(5):2001-2012. | ||||
REF 7 | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. Mol Cell. 2017 Jan 19;65(2):347-360. | ||||
REF 8 | Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. J Biol Chem. 2000 Jun 9;275(23):17263-8. | ||||
REF 9 | Negative regulation of PYK2/related adhesion focal tyrosine kinase signal transduction by hematopoietic tyrosine phosphatase SHPTP1. J Biol Chem. 1999 Oct 22;274(43):30657-63. | ||||
REF 10 | Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C. J Biol Chem. 1995 Sep 8;270(36):21277-84. | ||||
REF 11 | Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation. J Immunol. 1999 Mar 1;162(5):2717-24. | ||||
REF 12 | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. Mol Cell Proteomics. 2016 Sep;15(9):3030-44. | ||||
REF 13 | Regulation of Bcr-Abl-induced SAP kinase activity and transformation by the SHPTP1 protein tyrosine phosphatase. Oncogene. 1998 Oct 15;17(15):1889-92. | ||||
REF 14 | Constitutive association of SHP-1 with leukocyte-associated Ig-like receptor-1 in human T cells. J Immunol. 2001 Feb 1;166(3):1763-70. | ||||
REF 15 | Identification and characterization of leukocyte-associated Ig-like receptor-1 as a major anchor protein of tyrosine phosphatase SHP-1 in hematopoietic cells. J Biol Chem. 2000 Jun 9;275(23):17440-6. | ||||
REF 16 | PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRbeta. J Biol Chem. 2000 Feb 11;275(6):4467-74. | ||||
REF 17 | Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates. J Biol Chem. 1998 Oct 23;273(43):28332-40. | ||||
REF 18 | Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31. FEBS Lett. 1999 Apr 30;450(1-2):77-83. | ||||
REF 19 | Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells. J Exp Med. 1996 Aug 1;184(2):457-63. | ||||
REF 20 | SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J Biol Chem. 1998 Oct 16;273(42):27518-23. | ||||
REF 21 | SHP-1 requires inhibitory co-receptors to down-modulate B cell antigen receptor-mediated phosphorylation of cellular substrates. J Biol Chem. 2001 Jul 13;276(28):26648-55. | ||||
REF 22 | Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22. J Biol Chem. 1999 Jan 22;274(4):2303-7. | ||||
REF 23 | Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1. J Biol Chem. 2000 Feb 11;275(6):4066-71. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.